Discover
BVS
Bioventus Inc.
13.85
1 x 13.50
2 x 14.56
bid
ask
-
0.11
0.79%
3089 @ 04:00 PM
13.85 +0.00 (0.00%)
| Ytd | 86.16% | |
| 1y | 99.86% |
13.76
day range
13.98
6.25
52 week range
15.89
| Open | 13.81 | Prev Close | 13.96 | Low | 13.76 | High | 13.98 | Mkt Cap | 938.31M |
| Vol | 0.00 | Avg Vol | 757.65K | EPS | 0.76 | P/E | 18.22 | Forward P/E | 13.08 |
| Beta | 0.65 | Short Ratio | 3.11 | Inst. Own | 78.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 10.87 | 200-d Avg | 9.05 | 1yr Est | 14.80 |
| Income Statement | |||
| Total Revenue | 153.21M | ||
| Revenues (USD) | 153.21M | ||
| Cost of Revenue | 47.54M | ||
| Gross Profit | 105.67M | ||
| Operating Expenses | 90.36M | ||
| Research and Development Expense | 3.17M | ||
| Selling, General and Administrative Expense | 82.74M | ||
| Operating Income | 15.31M | ||
| Interest Expense | 4.07M | ||
| Income Tax Expense | -20.90M | ||
| Net Income | 33.44M | ||
| Net Income Common Stock | 33.44M | ||
| Net Income Common Stock (USD) | 33.44M | ||
| Consolidated Income | 36.21M | ||
| Net Income to Non-Controlling Interests | 2.76M | ||
| Earnings per Basic Share | 0.49 | ||
| Earnings per Basic Share (USD) | 0.49 | ||
| Earnings per Diluted Share | 0.47 | ||
| Earning Before Interest & Taxes (EBIT) | 16.61M | ||
| Earning Before Interest & Taxes (USD) | 16.61M | ||
| Weighted Average Shares | 67.87M | ||
| Weighted Average Shares Diluted | 70.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 29.46M | ||
| Cash and Equivalents (USD) | 29.46M | ||
| Investments | 3.51M | ||
| Investments Non-Current | 3.51M | ||
| Trade and Non-Trade Receivables | 138.41M | ||
| Current Assets | 257.53M | ||
| Property, Plant & Equipment Net | 24.75M | ||
| Total Assets | 673.35M | ||
| Debt Current | 18.75M | ||
| Total Debt | 248.45M | ||
| Current Liabilities | 152.45M | ||
| Debt Non-Current | 229.70M | ||
| Total Liabilities | 395.93M | ||
| Accumulated Retained Earnings (Deficit) | -298.37M | ||
| Accumulated Other Comprehensive Income | -1.33M | ||
| Shareholders Equity | 228.31M | ||
| Shareholders Equity (USD) | 228.31M | ||
| Assets Non-Current | 415.82M | ||
| Total Debt (USD) | 248.45M | ||
| Goodwill and Intangible Assets | 358.51M | ||
| Inventory | 79.81M | ||
| Liabilities Non-Current | 243.48M | ||
| Trade and Non-Trade Payables | 20.20M | ||
| Tax Assets | 29.05M | ||
| Tax Liabilities | 568.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 10.95M | ||
| Net Cash Flow from Financing | -23.43M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.39M | ||
| Capital Expenditure | -960.00K | ||
| Issuance (Purchase) of Equity Shares | 853.00K | ||
| Issuance (Repayment) of Debt Securities | -23.75M | ||
| Net Cash Flow from Investing | -2.46M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1.50M | ||
| Net Cash Flow from Operations | 19.87M | ||
| Effect of Exchange Rate Changes on Cash | -370.00K | ||
| Share Based Compensation | 5.04M | ||